Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.

Frontiers in immunology - 1 Jan 2021

Barnes Samantha A, Trew Isabella, de Jong Emma, Foley Bree

Abstract excerpt

Over the past 20 years natural killer (NK) cell-based immunotherapies have emerged as a safe and effective treatment option for patients with relapsed or refractory leukemia. Unlike T cell-based therapies, NK cells harbor an innate capacity to eliminate malignant cells without prior sensitization and can be adoptively transferred between individuals without the need for extensive HLA matching. A wide variety of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Immunotherapy
Share to Killer Cells, Natural
Share to Phenotype

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Open in PubMed Open full text

Identifiers

PMID: 34777383
DOI: 10.3389/fimmu.2021.765705
PMCID: PMC8578927

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 7 Sept 2026. Manifest publication-graph-cohort-2026-09-08.1.

Source receipt: pubmed, retrieved 7 Sept 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Making a Killer: Selecting the Optimal Natural Killer Cells for Improved Immunotherapies.PMID 34777383Read ↗

Improving the Outcome of Leukemia by Natural Killer Cell-Based Immunotherapeutic StrategiesSemantic proximity Read ↗

High-Risk Leukemia: Past, Present, and Future Role of NK CellsSemantic proximity Read ↗

Natural killer cell therapy for hematologic malignancies: successes, challenges, and the futureSemantic proximity Read ↗

Advantages and clinical applications of natural killer cells in cancer immunotherapy.Semantic proximity Read ↗

Natural killer cell‐based immunotherapy in cancer: current insights and future prospectsSemantic proximity Read ↗

Dark NKnight rising: a current perspective on NK cell and CAR-NK cell therapySemantic proximity Read ↗

CD56 as a marker of an ILC1-like population with NK cell properties that is functionally impaired in AMLSemantic proximity Read ↗

Bringing natural killer cells to the clinic: ex vivo manipulationSemantic proximity Read ↗

Markers and function of human NK cells in normal and pathological conditions.Semantic proximity Read ↗

Human NK cells and cancerSemantic proximity Read ↗

The diversity of natural killer cell functional and phenotypic states in cancer.Semantic proximity Read ↗

Bulk and single-cell transcriptomics identify gene signatures of stem cell-derived NK cell donors with superior cytolytic activitySemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.